$15.42
-2.02-11.58%
Last update: Oct 30, 7:55 PM
Scribe Therapeutics Inc (SCTX) Stock Price, Quote, News & History
SCTXNASDAQ
Cathie Wood's ARK dumps $18M of Twist Bioscience while buying Recursion, Veracyte and Intellia, extending its CRISPR bet to 50 sessions.
You can purchase shares of Scribe Therapeutics (NASDAQ:SCTX) through any online brokerage.
Other companies in Scribe Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Scribe Therapeutics has a consensus price target of $51.75.
The stock price for Scribe Therapeutics (NASDAQ: SCTX) is $15.25 last updated October 30, 2026 at 7:55 PM EDT.
There are no upcoming dividends for Scribe Therapeutics.
Scribe Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Scribe Therapeutics.
Scribe Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic...
